Pharmaceutical industry

BRUKINSA is changing

In October 2026, BRUKINSA (zanubrutinib) capsules were replaced by a tablet formulation, halving the number of tablets patients take each day. Here’s what pharmacists need to know about the switch, and how to support patients through the transition.…

Promotional content

Insulin pen design can lead to missed doses for people with disabilities, patient safety investigation body finds

The Health Services Safety Investigations Body said that patients with disabilities “experience recurring issues” with insulin pen devices.…

Medicines regulator to outsource some drug assessment work to private firms

The Medicines and Healthcare products Regulatory Agency said that three companies have been given contracts to provide assessments of clinical and non-clinical regulatory data.…

New medicines need workable pathways towards delivery, not just formulary approval

Even after MHRA approval, a NICE recommendation and formulary inclusion, there is still a long way to go before patients can benefit from new medicines.…

Is our medicines supply chain stretched to breaking point?

Amid growing geopolitical turbulence, have the realities of the NHS’s medicine supply resilience been overlooked?…

Pharmacy owners may have 28 days to appoint new superintendent pharmacist, under revised GPhC proposals

Following a consultation on the proposals, which revealed conflicting views on how soon a new superintendent pharmacist should be appointed, the General Pharmaceutical Council said it would clarify the timeframe in the final standards.…

Government to set out next steps on pharmacist dispensing flexibilities ‘in the coming weeks’

The Pharmacy All Party Parliamentary Group has called on the government to publish its consultation response “without delay”, warning that pharmacy teams are still absorbing much of the impact of medicines shortages.…

Regulator to use AI for earlier safety signals and overhaul patient information by 2030

In its five-year strategy, the Medicines and Healthcare products Regulatory Agency has also pledged to publish an AI medicines development plan in 2027 for the “safe and effective use of AI”.…

Industry gifts and payments can influence prescribing, Cochrane review finds

The Cochrane review authors noted that food and drink, consultancy payments, and educational expenses were among offers associated with ‘inappropriate’ authorisations.…

Self-administered injections should be considered for reclassification, says OTC body

PAGB calls for change to medication legislation so that injectable products could be reclassified to P medicines.…